Regional Cerebral Blood Flow Single Photon Emission Computed Tomography for detection of Frontotemporal dementia in people with suspected dementia

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 6, 2015, Pages

  Archer, Hilary A ^a   Smailagic, Nadja ^b   John, Christeena ^c   Holmes, Robin B ^d   Takwoingi, Yemisi ^e   Coulthard, Elizabeth J ^f   Cullum, Sarah ^g  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

^d Bristol General Hospital   (United Kingdom)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f NORTH BRISTOL NHS TRUST   (United Kingdom)

^g UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FRONTOTEMPORAL DEMENTIA; HUMAN; MULTIPLE HEADED CAMERA REGIONAL CEREBRAL BLOOD FLOW SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; NEUROLOGIC DISEASE ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMFORT; PATIENT SAFETY; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGIONAL CEREBRAL BLOOD FLOW SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; REVIEW; SECONDARY HEALTH CARE; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SINGLE HEADED CAMERA REGIONAL CEREBRAL BLOOD FLOW SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; SYSTEMATIC REVIEW; TERTIARY HEALTH CARE; TREATMENT OUTCOME; BRAIN CIRCULATION; CASE CONTROL STUDY; COHORT ANALYSIS; DEMENTIA; FRONTAL LOBE; PATHOPHYSIOLOGY; PROCEDURES; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE; VASCULARIZATION;

CASE-CONTROL STUDIES; CEREBROVASCULAR CIRCULATION; COHORT STUDIES; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FRONTAL LOBE; FRONTOTEMPORAL DEMENTIA; HUMANS; SENSITIVITY AND SPECIFICITY; TEMPORAL LOBE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84947082107     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010896.pub2     Document Type: Review

References (98)

1. Boutoleau-Bretonniere C, Lebouviera T, Delaroche O, Lamy E, Evrard C, Charriau T, et al. Value of neuropsychological testing, imaging, and CSF biomarkers for the differential diagnosis and prognosis of clinically ambiguous dementia. Journal of Alzheimer's Disease 2012;28(2):323-36.
2. Horn JF, Habert MO, Giron A, Fertil B. Alzheimer's disease and frontotemporal dementia differential automatic diagnosis based on SPECT images. Biomedical Imaging: From Nano to Macro, 2007. ISBI 2007. 4th IEEE International Symposium on Biomedical Imaging; 2007 April 12-15; Arlington, VA, USA. IEEE, 2007:1336-9.
3. Horn JF, Habert MO, Kas A, Malek Z, Maksud P, Lacomblez L, et al. Differential automatic diagnosis between Alzheimer's disease and frontotemporal dementia based on perfusion SPECT images. Artificial Intelligence in Medicine 2009;47(2):147-58.
4. Launes J, Sulkava R, Erkinjuntti T, Nikkinen P, Lindroth L, Liewendahl K, et al. 99Tcm-HMPAO SPECT in suspected dementia. Nuclear Medicine Communications 1991;12(9):757-65.
5. Lipton AM, Benavidesa R, Hynan LS, Bonte FJ, Harris TS, White CL, et al. Lateralization on neuroimaging does not differentiate frontotemporal lobar degeneration from Alzheimer's disease. Dementis and Geriatriatric Cognitive Disorders 2004;17(4):324-7.
6. McNeill R, Sare GM, Manoharan M, Testa HJ, Mann DM, Neary D, et al. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry 2007;78(4):350-5.
7. Nagao M, Sugawara Y, Ikeda M, Fukuhara R, Hokoishi K, Murase K, et al. Heterogeneity of cerebral blood flow in frontotemporal lobar degeneration and Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging 2004;31(2):162-8.
8. Pickut BA, Saerens J, Marien P, Borggreve F, Goeman J, Vandevivere J, et al. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type. Journal of Nuclear Medicine 1997;38(6):929-34.
9. Read SL, Miller BL, Mena I, Kim R, Itabashi H, Darby A. SPECT in dementia: clinical and pathological correlation. Journal of the American Geriatrics Society 1995;43(11):1243-7.
10. Rollin-Silliare A, Bombois S, Deramecourt V, Steinert-Emptaz A, Salleron J, Morvan J, et al. Contribution of single photon emission computed tomography to the differential diagnosis of dementia in a memory clinic. Journal of Alzheimer's Disease 2012;30(4):833-45.
11. Talbot PR, Lloyd JJ, Snowden JS, Neary D, Testa HJ. A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia?. Journal of Neurology, Neurosurgery, and Psychiatry 1998;63(3):306-13.
12. Valotassiou V, Papatriantafyllou J, Sifakis N, Tzavara C, Tsougos I, Kapsalaki E, et al. Perfusion SPECT studies with mapping of Brodmann areas in differentiating Alzheimer's disease from frontotemporal degeneration syndromes. Nuclear Medicine Communications 2012;33(12):1267-76.
13. Valotassiou V, Papatriantafyllou J, Sifakis N, Tzvara C, Tsougos J, Kapsalaki E, et al. Brain perfusion SPECT with Brodmann areas mapping in the differential diagnosis of Alzheimer's disease from behavioural variant of frontotemporal lobar degeneration. European Journal of Nuclear Medicine and Molecular Imaging 2011;38(Suppl 2):S260-441.
14. Barnes A, Lusman D, Pattersona J, Brown D, Wyper D. The use of statistical pParametric mapping (SPM96) as a decision aid in the differential diagnosis of dementia using 99mTc-HMPAO SPECT. Behavioural Neurology 2000;12(1-2):77-86.
15. Barquero MS, Dominguez M, Encinas M, Barabash A, Cabranes JA, Varela de Seijas E. Primary progressive aphasia: diagnosis and evolution using brain SPECT. Fifth International Conference on Alzheimer's Disease and Related Disorders. Osaka, Japan July 1996. Neurobiology of Aging. 1996; Vol. 17(4), issue 4 Suppl:S92.
16. Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 2012;135:765-83.
17. Bonte F, Tintner R, Weiner M, Bigio E, White C. Histopathological validation of brain blood flow SPECT in the differential diagnosis of the dementias. 39th annual Meeting of the Southwestern Chapter of the Society of Nuclear Medicine. Albuquerque, New Mexico, USA 1994. Clinical Nuclear Medicine. 1994; Vol. 19(3):260.
18. Bonte FJ, Harris TS, Roney CA, Hynan LS. Differential diagnosis between Alzheimer's and frontotemporal disease by the posterior cingulate sign. Journal of Nuclear Medicine 2004;45(5):771-4.
19. Borghesani PR, DeMers SM, Manchanda V, Pruthi S, Lewis DH, Borson S. Neuroimaging in the clinical diagnosis of dementia: observations from a memory disorders clinic. Journal of the American Geriatrics Society 2010;58(8):1453-8.
20. Borroni B, Agosti C, Premi E, Cerini C, Cosseddu M, Paghera B, et al. The FTLD-modified Clinical Dementia Rating scale is a reliable tool for defining disease severity in frontotemporal lobar degeneration: evidence from a brain SPECT study. European Journal of Neurology 2010;17(5):703-7.
21. Borronia B, Grassi M, Premi E, Alberici A, Cosseddu M, Cancelli V, et al. Is long-term prognosis of frontotemporal lobar degeneration predictable by neuroimaging? Evidence from a single-subject functional brain study. Journal of Alzheimer's Disease 2012;29(4):883-90.
22. Buchpiguel CA, Mathias SC, Itaya LY, Barros NG, Portela LA, Freitas JM, et al. Brain SPECT in dementia. A clinical-scintigraphic correlation. Arquivos de Neuro-psiquiatria 1996;54(3):375-83.
23. Didic M, Giusiano B, de Laforte C, Ceccaldi M, Poncet M. Identification of clinical subtypes of fronto-temporal dementia and cerebral blood flow on SPECT: preliminary results. Alzheimer's Reports 1998;1(3):179-85.
24. 99mTc-HMPAO SPECT) and clinical findings in the differentiation of Alzheimer's disease and dementia of frontal type. Third International Conference on Alzheimer's disease and related disorders. Abano Terme, Italy, July 1992. Neurobiol Aging. 1992; Vol. 13 Suppl 1:S16.
25. Frisoni GB, Pizzolato G, Geroldi C, Rossato A, Bianchetti A, Trabucchi M. Dementia of the frontal type: neuropsychological and [99Tc]-HM-PAO SPET features. Journal of Geriatric Psychiatry and Neurology 1995;8(1):42-8.
26. Grace J, Zawacki TM, Ott BR, Boyle P, Noto R. Behavioral, neuropsychological, and SPECT correlates of frontal lobe functioning in dementia. Brain and Cognition. 2001; Vol. 47, issue 1-2:279-82.
27. Hannequin D, Lefevre MHS, Bakchine S, Kotzki PO, Vera P. Primary progressive aphasia: a bilateral temporal lobe involvment. Neurology. 2001; Vol. 56, issue Suppl 3:A189.
28. Hogh P, Teller AS, Hasselbalch SG, Waldemar G. Clinical progression of MCI or questionable dementia and predictive value of HMPAO-SPECT: Follow-up study of 115 patients from a multidisciplinary memory clinic based in neurology. 9th International Conference on Alzheimer's Disease and Related Disorders. Philadelphia, USA July 2004. Neurobiology of Aging. 2004; Vol. 25 Suppl 2:S272.
29. Honda N, Machida K, Hosono M, Matsumoto T, Matsuda H, Oshima M, et al. Interobserver variation in diagnosis of dementia by brain perfusion SPECT. Radiation Medicine 2002;20(6):281-9.
30. Josephs KA, Duffy JR, Strand EA, Whitwell JL, Layton KF, Parisi JE, et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 2006;129(Pt 6):1385-98.
31. Julin P, Wahlund LO, Basun H, Persson A, Måre K, Rudberg U. Clinical diagnosis of frontal lobe dementia and Alzheimer's disease: relation to cerebral perfusion, brain atrophy and electroencephalography. Dementia 1995;6(3):142-7.
32. Kaneko K, Kuwabara Y, Sasaki M, Ogomori K, Ichimiya A, Koga H, et al. Posterior cingulate hypoperfusion in Alzheimer's disease, senile dementia of Alzheimer type, and other dementias evaluated by three-dimensional stereotactic surface projections using Tc-99m HMPAO SPECT. Clinical Nuclear Medicine 2004;29(6):362-6.
33. Le Ber I, Guedj E, Gabelle A, Verpillat P, Volteau M, Thomas-Anterion C, et al. Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia. Brain 2006;129(Pt 11):3051-65.
34. Lojkowska W, Ryglewicza D, Jedrzejczak T, Sienkiewicz-Jarosz H, Minc S, Jakubowska T, et al. SPECT as a diagnostic test in the investigation of dementia. Journal of the Neurological Sciences 2002;203-204:215-9.
35. Mendez MF, Shapira JS, McMurtray A, Licht E, Miller BL. Accuracy of the clinical evaluation for frontotemporal dementia. Archives of Neurology 2007;64(6):830-5.
36. Miller BL, Ikonte C, Ponton M, Levy M, Boone K, Darby A, et al. A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology 1997;48(4):937-42.
37. Miller BL, Gearhart R. Neuroimaging in the diagnosis of frontotemporal dementia. Dementia and Geriatric Cognitive Disorders 1999;10(Suppl 1):71-4.
38. 99mTc-HMPAO SPECT study. Current Alzheimer Research 2013;10(3):332-9.
39. Sjögren M, Gustafson L, Wikkelsö C, Wallin A. Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio. Dementia and Geriatric Cognitive Disorders 2000;11(5):275-85.
40. Talbot PR, Snowden JS, Lloyd JJ, Neary D, Testa HJ. The contribution of single photon emission tomography to the clinical differentiation of degenerative cortical brain disorders. Journal of Neurology 1995;242(9):579-86.
41. Valotassiou V, Papatriantafyllou J, Sifakis N, Karageorgiou C, Tsougos I, Tzavara C, et al. Evaluation of brain perfusion in specific Brodmann areas in frontotemporal dementia and Alzheimer disease using automated 3-D voxel based analysis. Journal of Instrumentation 2009;4:doi:10.1088/1748-0221/4/05/P05020.
42. Valotassiou V, Papatriantafyllou J, Sifakis N, Tzavara C, Tsougos J, Psimadas D, et al. Evaluation of perfusion differences in semantic dementia and Alzheimer's disease using Tc-99m-HMPAO SPECT with automated Brodmann areas mapping. European Journal of Nuclear Medicine and Molecular Imaging 2011;38(Suppl 2):S323.
43. Valotassiou V, Papatriantafyllou J, Sifakis N, Tzavara C, Tsougos J, Psimadas D, et al. Alzheimer's disease and progressive non-fluent aphasia: evaluation of perfusion differences using 99mTc-HMPAO SPECT and Brodmann areas mapping. 25th Annual Congress of the European Association of Nuclear Medicine (EANM) Milan Italy Oct 2012. European Journal of Nuclear Medicine and Molecular Imaging. 2012; Vol. 39 (Suppl 2):S547.
44. Valotassiou V, Papatriantafyllou J, Sifakis N, Tzavara C, Tsougos J, Psimadas D, et al. Patterns of perfusion deficit in semantic dementia and progressive non-fluent aphasia: a Tc-99m-HMPAO SPECT study with Brodmann areas mapping. 25th Annual Congress of the European Association of Nuclear Medicine (EANM) Milan Italyn Oct 2012. European Journal of Nuclear Medicine and Molecular Imaging. 2012; Vol. 39(Suppl 2):S547.
45. Waragai M, Mizumura S, Yamada T, Matsuda H. Differentiation of early-stage Alzheimer's disease from other types of dementia using brain perfusion single photon emission computed tomography with easy Z-score imaging system analysis. Dementia and Geriatric Cognitive Disorders 2008;26(6):547-55.
46. Alzheimer's Disease International. World Alzheimer report 2010. The global economic impact of dementia. www.alz.co.uk/research/files/WorldAlzheimerReport2010.pdf 2010 (accessed 14 May 2015).
47. Alzheimer's Society. Dementia UK 2007. www.alzheimers.org.uk/site/scripts/download_info.php?fileID=2 2007 (accessed 14 May 2015).
48. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. http://dsm.psychiatryonline.org//book.aspx?bookid=556 2013 (accessed 14 May 2015).
49. Ball MG, Braak H, Coleman P, Dickson D, Duyckaerts C, Gambetti P, et al. Consensus recommedations for the postmortem diagnosis of Alzheimer's disease: The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. neurobiology of Aging 1997;18:S1-S2.
50. Brun A, England B, Gustafson L, et al. Clinical and neuropathological criteria for frontotempora;l dementia. Journal of Neurology, Neurosurgery and Psychiatry 1994;57:416-8.
51. Cairns NG, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, et al. Consortium for Frontotemporal Lobar Degeneration.Neuropathologic diagnostic and nosologic criteria for frontotempolar lobar degeneration: Consensus of the consortium for frontotemporal lobar degeneration. Acta Neuropathologica 2007;114:5-22.
52. Catafau AM. Brain SPECT in clinical practice. Part I: perfusion. Journal of Nuclear Medicine 2001;42(2):259-71.
53. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992;42(3 Pt 1):473-80.
54. Chung HW, Huang YH. Fractal analysis of nuclear medicine images for the diagnosis of pulmonary emphysema:interpretations, implications, and limitations. American Journal of Roentgenology 2000;174:1055-9.
55. Davis DHJ, Creavin ST, Noel-Storr A, Quinn TJ, Smailagic N, Hyde C, et al. Neuropsychological tests for the diagnosis of Alzheimer's disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies. Cochrane Database of Systematic Reviews 2013, Issue 3. [DOI: 10.1002/14651858.CD010460]
56. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366(9503):2112-7.
57. Geslani DM, Tierney MC, Herrmann N, Szalai JP. Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2005;19(5-6):383-9.
58. Gibb WR, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 1989;112:1171-92.
59. Glanville JM, Cikalo M, Crawford F, Dozier M, Lowson P. Handsearching for reports of diagnostic test accuracy studies: adding to the evidence base. Oral presentation at the Joint Cochrane and Campbell Colloquium; 2010 Oct 18-22; Keystone, Colorado, USA [abstract]. CMR Metodologia Cochrane ID:CMR 15328. 2010; Vol. Suppl:48.
60. Hendrie HC, Hall KS, Brittain HM, Austrom MG, Farlow M, Parker J, et al. The CAMDEX: a standardized instrument for the diagnosis of mental disorder in the elderly: a replication with a US sample. Journal of the American Geriatrics Society 1988;36(5):402-8.
61. Hokoishi K, Ikeda M, Maki N, et al. Frontotemporal lobar degeneration: a study in Japan. Dementia and Geriatric Cognitive Disorders 2001;12:393-9.
62. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001;57:1497-99.
63. Juni JE, Waxman AD, Devous MD Sr, Tikofsky RS, Ichise M, Van Heertum RL, et al. Procedure guideline for brain perfusion SPECT using (99m)Tc radiopharmaceuticals 3.0. Journal of Nuclear Medicine Technology 2009;37(3):191-5.
64. Kapucu OL, Nobili F, Varrone A, Booij J, Vander Borght T, Någren K, et al. EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2. European Journal of Nuclear Medicine and Molecular Imaging 2009;36(12):2093-102.
65. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56(9):1143-53.
66. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
67. Clinical and neuropathological criteria forfrontotemporal dementia. The Lund and Manchester Groups. Journal of Neurology, Neurosurgery, and Psychiatry 1994;57(4):416-8.
68. Mackenzie IRA, Neumann M, Bigio EH, Cairns NG, Alafuzoff I, Kril J, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathologica 2010;119(1):1-4.
69. Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathologica 2011;122(1):111-3.
70. Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T, et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 2012;135(Pt 3):736-50.
71. Mann DMA, South PW. The topographic distributaion of brain atrophy in frontal lobe dementia. Acta Neuropathologica 1993;85:334-40.
72. Matthews FE, Brayne C, Lowe J, McKeith I, Wharton SB, Ince P. Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Medicine 2009;6(11):e1000180.
73. McKeith IG, Dickson DW, Lowe J, Emre M, O' Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 2005;65:1863-72.
74. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34(7):939-44.
75. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ, et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Archives of Neurology 2001;58(11):1803-9.
76. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 2011;7(3):263-9.
77. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41(4):479-86.
78. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine 2009;151(4):264-9.
79. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001;357(9251):169-75.
80. Nagao M, Murase K. Measurement of heterogeneous distribution on Technegas SPECT images by three-dimensional fractal analysis. Annals of Nuclear medicine 2002;16(6):369-76.
81. National Audit Office. Improving services and support for people with dementia. http://www.nao.org.uk/wp-content/uploads/2007/07/0607604.pdf 4 July 2007 (accessed 14 May 2015).
82. Neary D, Snowden JS, Bowen DM, et al. Neuropsychological syndromes in presenile dementia due to cerebral atrophy. Journal of Neurology, neurosurgery, and Psychiatry 1986;49:163-74.
83. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51(6):1546-54.
84. National Institute for Health and Care Excellence. Dementia: supporting people with dementia and their carers in health and social care. Clinical guidelines CG42. http://guidance.nice.org.uk/CG42/NICEGuidance/pdf/English November 2006 (accessed 14 May 2015).
85. Okello A, Koivunen J, Edison P, Archer HA, Turkhemer FE, Nagren K, et al. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology 2009;73(10):754-60.
86. Rascovsky K, Hodges JR, Kipps CM, Johnson JK, Seeley WW, Mendez MF, et al. Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Disease and Associated Disorders 2007;21(4):S14-8.
87. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011;134(Pt 9):2456-77.
88. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology 2002;58(11):1615-21.
89. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manage (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2013.
90. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43(2):250-60.
91. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C. Age, neuropathology, and dementia. The New England Journal of Medicine 2009;360(22):2302-9.
92. Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. Journal of Neurology, Neurosurgery, and Psychiatry 2011;82(5):476-86.
93. Shi J, Shaw CL, Richardson AMT, et al. Hystopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation. Acta Neuropathologica 2005;110:501-12.
94. Steinling M, Mazingue A, Kassiotis P, Gaudet Y, Fialdes P, Duhamel A, et al. MmPaO TC as an indicator of local cerebral blood flow: Quantfied study compared to xenon 133 inhalation method. Annals of Radiology 1988;31:229-38.
95. Steinling M, Leys D, Amagassi F, Soetart G, Vernes R. Can Alzheimer and multi infarct dementia be differentiated using 99m-Tc-HMPAO tomograms. In: Circulation cerebrale et viellissement, G Geraud-A Bes, Eds.John Libbey Eurotext 1989:291-4.
96. Visser PJ, Kester A, Jolles J, Verhey F. Ten-year risk of dementia in subjects with mild cognitive impairment. Neurology 2006;67(7):1201-7.
97. Whiting P, Westwood M, Beynon R, Burke M, Sterne JA, Glanville J. Inclusion of methodological filters in searches for diagnostic test accuracy studies misses relevant studies. Journal of Clinical Epidemiology 2011;64(6):602-7.
98. World Health Organization. International Classification of Diseases and Related Health Problems 10th revision (ICD-10). http://www.who.int/entity/classifications/icd/ICD10Volume2_en_2010.pdf 2010 (accessed 14 May 2015).